Michael Gelband’s Aurora Cannabis ACB Stock Holding History

Michael Gelband’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,350	Closed	-$528K	–	2066
2020 Q4	$528K	Buy	+6,350	New	+$463K	0.01%	1216

Other funds holding ACB

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Michael Gelband's ACB Position: Q2 2022 in Review

Michael Gelband sold out of Aurora Cannabis (ACB) in Q2 2022, closing a stake of 2,672 shares — an estimated $107K sold.

Michael Gelband first reported a position in ACB in Q2 2020 and held it in 2 quarters. The position peaked at $170K in Q2 2020. 257 funds tracked by Wall St. Rank hold ACB as of Q2 2022.

Michael Gelband reported no remaining Aurora Cannabis position as of Q2 2022 after selling out during the quarter.
Michael Gelband sold 2,672 Aurora Cannabis shares in Q2 2022, an estimated $107K.
Michael Gelband first reported a position in Aurora Cannabis in Q2 2020 and held it in 2 quarters.
Michael Gelband's Aurora Cannabis position peaked at $170K in Q2 2020.
257 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.